Journal article
Treating Generalized Anxiety Disorder With Second Generation Antipsychotics
Abstract
Most individuals with generalized anxiety disorder (GAD) fail to achieve remission despite standard treatments. As a result, we examined the efficacy and tolerability of second-generation antipsychotics (SGAs) as (a) augmentation or (b) monotherapy for GAD. We searched MEDLINE, EMBASE, PsycINFO, the Cochrane Library, controlled trials databases, and the abstracts of scientific meetings for all trials of GAD treatment with SGAs in adults. …
Authors
Lalonde CD; Van Lieshout RJ
Journal
Journal of Clinical Psychopharmacology, Vol. 31, No. 3, pp. 326–333
Publisher
Wolters Kluwer
Publication Date
June 2011
DOI
10.1097/jcp.0b013e31821b2b3f
ISSN
0271-0749